Evidence map›Paper›PMID 22179613›Full record

ArticleThe Journal of biological chemistry2012

Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.

Mel Campbell, Pei-Ching Chang, Steve Huerta, Chie Izumiya, Ryan Davis, Clifford G Tepper, Kevin Y Kim, Bogdan Shevchenko, Don-Hong Wang, Jae U Jung and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Protein arginine methylation in viral infection and antiviral immunity.International journal of biological sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mel CampbellDepartment of Dermatology, University of California, Davis, California 95616, USA.
Pei-Ching Chang
Steve Huerta
Chie Izumiya
Ryan Davis
Clifford G Tepper
Kevin Y Kim
Bogdan Shevchenko
Don-Hong Wang
Jae U Jung
Paul A Luciw
Hsing-Jien Kung
Yoshihiro Izumiya
University of California, Davis · USUniversity of Southern California · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
ORF36 Viral Kinase as a Transcriptional Regulator of KSHVP01DE019085 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2008 to 2012
$6.4M
K-Rta as a Novel SUMO and Epigenetic RegulatorR01CA147791 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IZUMIYA, YOSHIHIRO · 2010 to 2014
$1.5M
NCI NIH HHS P30 CA093373NCI NIH HHS P30 CA93373NCI NIH HHS R01 CA147791NCI NIH HHS R01-CA147791NIDCR NIH HHS P01 DE019085NIDCR NIH HHS P01-DE19085
6 · The paper itself

Abstract

The Kaposi sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a multifunctional protein with roles in gene regulation and maintenance of viral latency. Post-translational modification of LANA is important for functional diversification. Here, we report that LANA is subject to arginine methylation by protein arginine methyltransferase 1 in vitro and in vivo. The major arginine methylation site in LANA was mapped to arginine 20. This site was mutated to either phenylalanine (bulky hydrophobic, constitutive methylated mimetic) or lysine (positively charged, non-arginine methylatable) residues. The significance of the methylation in LANA function was examined in both the isolated form and in the context of the viral genome through the generation of recombinant KSHV. In addition, authentic LANA binding sites on the KSHV episome in naturally infected cells were identified using a whole genome KSHV tiling array. Although mutation of the methylation site resulted in no significant difference in KSHV LANA subcellular localization, we found that the methylation mimetic mutation resulted in augmented histone binding in vitro and increased LANA occupancy at identified LANA target promoters in vivo. Moreover, a cell line carrying the methylation mimetic mutant KSHV showed reduced viral gene expression relative to controls both in latency and in the course of reactivation. These results suggest that residue 20 is important for modulation of a subset of LANA functions and properties of this residue, including the hydrophobic character induced by arginine methylation, may contribute to the observed effects.

Indexed as

Antigens, ViralArginineBase SequenceBinding SitesChromatinGenetic EngineeringGenome, ViralHEK293 CellsHerpesvirus 8, HumanHistonesHumansIntracellular SpaceMethylationMutationNuclear ProteinsProtein-Arginine N-MethyltransferasesAntigens, ViralArginineChromatinHistoneslatency-associated nuclear antigenNuclear ProteinsPRMT1 protein, humanProtein-Arginine N-MethyltransferasesRepressor Proteins

Identifiers

PMID22179613
PMCPMC3285351
OpenAlexW1997447080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.